Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

被引:158
|
作者
Przedborski, S
Chen, QP
Vila, M
Giasson, BI
Djaldatti, R
Vukosavic, S
Souza, JM
Jackson-Lewis, V
Lee, VMY
Ischiropoulos, H
机构
[1] Columbia Univ, Dept Neurol, Neurosci Res Movement Disorder Div, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[3] Childrens Hosp Philadelphia, Stokes Res Inst, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
[5] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
dopaminergic neurons; MPTP; neurodegeneration; Parkinson's disease; substantia nigra; synuclein;
D O I
10.1046/j.1471-4159.2001.00174.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural and functional alterations of alpha -synuclein is a presumed culprit in the demise of dopaminergic neurons in Parkinson's disease (PD), alpha -Synuclein mutations are found in familial but not in sporadic PD, raising the hypothesis that effects similar to those of familial PD-linked alpha -synuclein mutations may be achieved by oxidative post-translational modifications. Here, we show that wild-type alpha -synuclein is a selective target for nitration following peroxynitrite exposure of stably transfected HEK293 cells. Nitration of alpha -synuclein also occurs in the mouse striatum and Ventral midbrain following administration of the parkinsonian neurotoxin 1-methyt-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Conversely, beta -synuclein and synaptophysin were not nitrated in MPTP-intoxicated mice. Our data demonstrate that alpha -synuclein is a target for tyrosine nitration, which, by disrupting its biophysical properties, may be relevant to the putative role of alpha -synuclein in the neurodegeneration associated with MPTP toxicity and with PD.
引用
收藏
页码:637 / 640
页数:4
相关论文
共 50 条
  • [1] Pathologic modifications of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) -: Treated squirrel monkeys
    McCormack, Alison L.
    Mak, Sally K.
    Shenasa, Maryam
    Langston, William J.
    Forno, Lysia S.
    Di Monte, Donato A.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (08): : 793 - 802
  • [2] 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated adult zebrafish as a model for Parkinson's Disease
    Bagwell, Emmeline
    Shin, Minhyun
    Henkel, Nicole
    Migliaccio, Doris
    Peng, Congyue
    Larsen, Jessica
    NEUROSCIENCE LETTERS, 2024, 842
  • [3] Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced mouse model of Parkinson's disease
    Yokoyama, Hironori
    Kuroiwa, Hayato
    Kasahara, Jiro
    Araki, Tsutomu
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2011, 71 (02) : 269 - 280
  • [4] Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model
    Czlonkowska, A
    Kohutnicka, M
    Kurkowska-Jastrzebska, I
    Czlonkowski, A
    NEURODEGENERATION, 1996, 5 (02): : 137 - 143
  • [5] Risk is in the Air An Intranasal MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Rat Model of Parkinson's Disease
    Prediger, Rui D. S.
    Rial, Daniel
    Medeiros, Rodrigo
    Figueiredo, Claudia P.
    Doty, Richard L.
    Takahashi, Reinaldo N.
    INTERNATIONAL SYMPOSIUM ON OLFACTION AND TASTE, 2009, 1170 : 629 - 636
  • [6] Neuroprotective effect of glycyrrhizin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
    Kim, D. E.
    Park, S. E.
    Han, J. H.
    JOURNAL OF NEUROLOGY, 2008, 255 : 165 - 165
  • [7] The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model - A tool to explore the pathogenesis of Parkinson's disease
    Przedborski, S
    Vila, M
    PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 : 189 - 198
  • [8] Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
    Park, Jihye
    Lim, Chae-Seok
    Seo, Hyunhyo
    Park, Chung-Ah
    Zhuo, Min
    Kaang, Bong-Kiun
    Lee, Kyungmin
    MOLECULAR PAIN, 2015, 11
  • [9] 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease in zebrafish
    Babu, Nukala Sarath
    Murthy, Ch Lakshmi N.
    Kakara, Sameera
    Sharma, Rahul
    Swamy, Cherukuvada V. Brahmendra
    Idris, Mohammed M.
    PROTEOMICS, 2016, 16 (09) : 1407 - 1420
  • [10] Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
    Kohutnicka, M
    Lewandowska, E
    Kurkowska-Jastrzebska, I
    Czlonkowski, A
    Czlonkowska, A
    IMMUNOPHARMACOLOGY, 1998, 39 (03): : 167 - 180